Patents by Inventor Ed Croze

Ed Croze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
    Patent number: 7138379
    Abstract: The present invention is directed towards a method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modified cells within the target cell population and then exposing the modified cells to a therapeutically effective amount of a type I IFN or by exposure to endogenously produced IFN.
    Type: Grant
    Filed: July 25, 2001
    Date of Patent: November 21, 2006
    Assignee: Schering Aktiengesellschaft
    Inventors: Ed Croze, David Vogel, Dean Russell-Harde
  • Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
    Publication number: 20020045593
    Abstract: The present invention is directed towards a method of potentiating the anti-growth effects of type I interferon (IFN) on cells in a target cell population comprising increasing the number of functional IFNAR2c receptors on the surface of modified cells within the target cell population and then exposing the modified cells to a therapeutically effective amount of a type I IFN or by exposure to endogenously produced IFN.
    Type: Application
    Filed: July 25, 2001
    Publication date: April 18, 2002
    Applicant: BERLEX BIOSCIENCES
    Inventors: Ed Croze, David Vogel, Dean Russell-Harde